How could low-dose aspirin help women with miscarriage risk during Pregnancy?

Being a mother is one of the most significant gifts for a woman as she learns and begins to embrace love more closely and passionately more than earlier. But at the same time, losing a child even before giving birth to him/her could be traumatic for any woman. The days during pregnancy require a woman to be more cautious and mindful of her habits.

One may love to eat something in excess or have drinking habits, but it might not be ideal to do the same thing during the pregnancy phase. The body goes through a transitional phase during the pregnancy period, and some might experience the risk of miscarriage more than others.

There may be several factors behind why some women are more prone to pregnancy loss as genetic factors are too involved. But a recent study has brought forward a new theory where it says about low-dose aspirin might be able to reduce this risk of pregnancy in women who had a history of miscarriages.

The study was conducted at the American College of Physicians was later published in the American College of Physicians as a report. The researchers claimed that for aspirin therapy to work, a woman should start consuming it before conceiving for at least four days a week regularly.

When the researchers conducted the study, their end-result showed a significant increase in the successful pregnancy period and reduced miscarriages in many women. It all happened because all these women made it a point to keep their low-dose of aspirin therapy consistent till before conceiving and during their pregnancy period.

The effect of aspirin on Pregnancy: The Study

Health data from gestation and reproduction trials (EAGeR) was analyzed by a group of researchers from Emory University and the National Institutes of Health. It included the data of 1,227 women in total who were trying to conceive and already had a history of at least two miscarriages earlier.

The result of this data analysis at first showed no improvements in the risk of pregnancy in these women. But after multiple tests and analysis of factors like how strictly these women followed their dose of aspirin, it came to light that after taking a lose-dose of aspirin for at least four days a week, there were eight successful pregnancies, only six pregnancy loss, and 15 successful births. The statistics meant that aspirin showed success in about 30 percent of women.

Aspirin is mainly recommended to women who suffer from high blood pressure during pregnancy (Preeclampsia) or Blood clots caused by an autoimmune disease during pregnancy (Antiphospholipid Syndrome). Both the conditions could cause harm to the child and the mother posing the risk of miscarriage.

Aspirin in both these cases is recommended for a proper flood flow around the placenta which keeps the baby and the mother healthy. Since aspirin is a blood-thinning medication, it always improves the blood flow and removes any clots and danger to the child.

The Concluding Idea

Although the study has placed aspirin as one way to prevent miscarriages in women, it is essential to know that aspirin might not be a suitable option for those who have the risk of excessive bleeding since aspirin is a blood-thinning medication.

Some women are allergic to nonsteroidal medications such as aspirin itself. These women need to look for other alternatives and talk to their gynecologist for a solution better than this and look for an option that could save their baby.

Meanwhile, this study has said that women who suffer from autoimmune and inflammatory conditions should consider taking a low-dose of aspirin. In more severe blood clotting conditions or danger to the baby, doctors go for anticoagulation medication that could benefit the mother.

One also needs to remember that aspirin medication doesn’t need to be the only thing that one needs to take care of, but looking out for good health and lifestyle before and during pregnancy is equally important to avoid being at risk of pregnancy loss.

Leave a Reply

Your email address will not be published. Required fields are marked *